Track Treace Medical Concepts's accounts payable ($16M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Treace Medical Concepts (TMCI) currently reports a accounts payable of $16M as of June 2026. That compares with $20M in the prior-year period — down 19.5% year over year. Use the charts on this page to explore Treace Medical Concepts's accounts payable history and peer comparisons.
Treace Medical Concepts's accounts payable decreased from $20M to $16M — a 19.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Treace Medical Concepts reported $16M in accounts payable as of June 2026. That compares with $20M in the prior-year period — down 19.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Treace Medical Concepts, and consider following TMCI for alerts when major investors trade the stock.
Treace Medical Concepts is classified in the Healthcare sector. On accounts payable, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TMCI with unrelated industries.